Gavin Macbeath serves as Executive at TScan Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Gavin Macbeath has executed 3 insider transactions totaling $31.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 20, 2026 involved receiving (via award) 1,165,000 shares valued at $0.
Gavin Macbeath currently holds 1,165,000 shares of TScan Therapeutics, Inc. (TCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gavin Macbeath has been a net buyer of TCRX stock. They have purchased $31.1K and sold $0 worth of shares.
Gavin Macbeath's most recent insider trade was on Jan 20, 2026, when they sold 1,165,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.19 |
| Discretionary |
| Sep 20, 2021 | TCRX | $30.7K | Purchase | 4,943 | $6.22 | Discretionary |